Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
This study aimed to systematically evaluate the clinical efficacy and safety of traditional Chinese medicine (TCM) compounds combined with standard treatments for diabetes mellitus (DM) complicated by coronary heart disease (CHD). We performed a systematic and comprehensive search of the China Knowledge Network, WanFang, WeiPu, PubMed, and Web of Science, including Chinese and English articles, for randomized controlled trials (RCTs) assessing the use of Chinese herbal compounds for the treatment of DM complicated by CHD published before June 1, 2020. The literature was screened according to standard criteria. Risk assessment, based on the Jadad scale, was performed using the Review Manager5.3 software for meta-analysis. In total, 23 articles were selected, including 2405 cases. The meta-analysis showed that the combination of standard treatments with TCM compounds significantly improved the overall treatment efficacy for DM complicated by CHD (OR(odds ratio) = 4.39; 95% confidence interval (95% CI), 3.30-5.84; < 0.0001), fasting blood glucose level (mean difference (MD) = -1.04; 95% CI, -1.96 to -0.13; =0.03), total cholesterol level (MD = -1.16; 95% CI, -1.48 to -0.83; < 0.0001), triglyceride (MD = -0.46; 95% CI, -0.62 to -0.29; < 0.0001), low-density lipoprotein level (MD = -0.57; 95% CI, -0.87 to -0.27; =0.0002), high-density lipoprotein level (MD = 0.19; 95% CI, 0.12 to 0.26; =0.02), and electrocardiogram (OR = 4.20; 95% CI, 3.15 to 8.18; < 0.0001). In contrast, there was no improvement of 2-hour postprandial glucose level (MD = -1.03; 95% CI, -2.14 to 0.08; =0.07), or adverse reactions (OR = 0.53; 95% CI, 0.19 to 5.50; =0.21). We concluded that the combined therapy has some benefits in treating DM complicated by CHD. However, these results should be confirmed by further referenced evidence, high risk assessment, and lower publication bias.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238557 | PMC |
| http://dx.doi.org/10.1155/2021/5515142 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Incidence and Outcomes of Pericardial Effusion After Congenital Heart Surgery.
World J Pediatr Congenit Heart Surg
September 2025
Texas Center for Pediatric and Congenital Heart Disease, The University of Texas at Austin Dell Medical School, Austin, TX, USA.
Pericardial effusion (PCE) represents a significant postoperative complication following congenital heart surgery (CHS), contributing to more complex postoperative care and heightened morbidity. In this study, we aim to elucidate the risk factors contributing to PCE development post-CHS through analysis of data from a nationwide, multi-institutional database. Review of the Pediatric Health Information System Database from January 1, 2004, to December 30, 2023.
View Article and Find Full Text PDFEffect of Jiuwei Zhenxin granules on serum TREM1 expression and its regulatory role in depression and anxiety in patients with coronary heart disease.
Medicine (Baltimore)
September 2025
Pediatric Laboratory, Hunan Provincial People's Hospital (The First Hospital Affiliated with Hunan Normal University) Laboratory Physician, Changsha, China.
This study explored the effects of Jiuwei Zhenxin (JWZX) granules on serum triggering receptor expressed on myeloid cells 1 (TREM1) levels and their role in regulating depression and anxiety in patients with coronary heart disease (CHD). A total of 100 CHD patients were enrolled from January 2020 to January 2023: 50 received JWZX granules and 50 underwent conventional treatment. Clinical data and psychological scores were collected.
View Article and Find Full Text PDFAcute stent placement for dynamic airway collapse after cardiac surgery in congenital heart disease with bronchial stenosis: A case report.
Medicine (Baltimore)
September 2025
Department of Cardiac Surgery, Chest Hospital, Tianjin University, Tianjin, China.
Rationale: Tracheomalacia, typically seen in relapsing polychondritis,[1] is rarely reported in association with congenital heart disease (CHD). In patients with pulmonary hypoperfusion-type CHD, surgical repair results in a rapid increase in pulmonary blood flow, predisposing them to mucus retention, airway obstruction, and respiratory distress. We describe acute airway collapse in a patient with double outlet right ventricle and congenital bronchial stenosis following cardiac repair.
View Article and Find Full Text PDFNomogram Model for Identifying the Risk of Coronary Heart Disease in Patients with Chronic Obstructive Pulmonary Disease Based on Deep Learning Radiomics and Clinical Data: A Multicenter Study.
Int J Chron Obstruct Pulmon Dis
September 2025
Department of Cardiovascular Center, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, People's Republic of China.
Objective: This study aimed to develop and validate a deep learning radiomics (DLR) nomogram for individualized CHD risk assessment in the COPD population.
Methods: This retrospective study included 543 COPD patients from two different centers. Comprehensive clinical and imaging data were collected for all participants.
Genetics of Congenital Heart Disease: A Narrative Review of Challenges and Strategies in Identifying Novel Genes.
Cureus
September 2025
Department of Paediatric Histopathology, Alder Hey Children's Hospital, Liverpool, GBR.
Congenital heart disease (CHD) is the most common congenital anomaly. While surgical and interventional advancements have improved survival, the management of associated complications and comorbidities remains complex and would benefit from a personalised approach that more accurately predicts individualised risks and prognoses. Recently, next-generation sequencing has uncovered diverse genetic factors, including epigenetic modifications, somatic mosaicism and regulatory non-coding variants.
View Article and Find Full Text PDF